Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna R Rivera

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
The Annals of Pharmacotherapy|December 7, 2013
Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic developmentDonna R Rivera, Abraham G Hartzema
Seminars in Radiation Oncology|September 2, 2019
The Contribution of Cancer Surveillance Toward Real World Evidence in OncologyLynne Penberthy, Donna R Rivera, Kevin Ward
JAMA Oncology|March 2, 2018
Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms-ReplyDonna R Rivera, Jeremy Brown, Nonniekaye Shelburne
The Oncologist|May 31, 2022
Blurring the Lines of Design: Prospective Observational Cohorts and Pragmatic Clinical Trials Characterizing Treatment Effects in Routine Cancer CareDonna R Rivera, Erin Larkins, Paul G Kluetz
Frontiers in Pharmacology|September 14, 2020
COVID-19 Usurps Host Regulatory NetworksColleen S Curran, Donna R Rivera, Jeffrey B Kopp
Annals of Epidemiology|November 14, 2016
Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomesDonna R Rivera, Katherine A McGlynn, Andrew N Freedman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 2019
Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United StatesMonica D'Arcy, Donna R Rivera, Andrew Grothen, et al.
The Lancet. Oncology|January 5, 2024
When less is more-reducing complexity in cancer trialsTimil H Patel, Donna R Rivera, Harpreet Singh, et al.
JCO Clinical Cancer Informatics|January 19, 2024
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision MakingCatherine C Lerro, Marie C Bradley, Richard A Forshee, et al.
Journal of the National Cancer Institute|September 28, 2017
Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic ReviewDonna R Rivera, Patricia A Ganz, Meghan S Weyrich, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
The Annals of Pharmacotherapy|December 7, 2013
Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic developmentDonna R Rivera, Abraham G Hartzema
Seminars in Radiation Oncology|September 2, 2019
The Contribution of Cancer Surveillance Toward Real World Evidence in OncologyLynne Penberthy, Donna R Rivera, Kevin Ward
JAMA Oncology|March 2, 2018
Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms-ReplyDonna R Rivera, Jeremy Brown, Nonniekaye Shelburne
The Oncologist|May 31, 2022
Blurring the Lines of Design: Prospective Observational Cohorts and Pragmatic Clinical Trials Characterizing Treatment Effects in Routine Cancer CareDonna R Rivera, Erin Larkins, Paul G Kluetz
Frontiers in Pharmacology|September 14, 2020
COVID-19 Usurps Host Regulatory NetworksColleen S Curran, Donna R Rivera, Jeffrey B Kopp
Annals of Epidemiology|November 14, 2016
Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomesDonna R Rivera, Katherine A McGlynn, Andrew N Freedman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 2019
Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United StatesMonica D'Arcy, Donna R Rivera, Andrew Grothen, et al.
The Lancet. Oncology|January 5, 2024
When less is more-reducing complexity in cancer trialsTimil H Patel, Donna R Rivera, Harpreet Singh, et al.
JCO Clinical Cancer Informatics|January 19, 2024
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision MakingCatherine C Lerro, Marie C Bradley, Richard A Forshee, et al.
Journal of the National Cancer Institute|September 28, 2017
Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic ReviewDonna R Rivera, Patricia A Ganz, Meghan S Weyrich, et al.
Pageof 9